Realbotix (XBOT.F) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 May, 2026Executive summary
Significant strategic progress made despite limited visible improvement in quarterly financials, with a full pivot from crypto to AI and robotics and upscaled staffing from 8 to over 20 employees in the segment.
Revenue for Q2-2026 was $225,000, down from $727,000 year-over-year, due to the exit from crypto operations and focus on AI-integrated humanoid robotics.
Operating expenses increased to $1,746,000 in Q2-2026, reflecting expanded hiring for robotics and AI divisions.
Total comprehensive income for Q2-2026 was $442,375, a significant improvement from a loss of $4,858,000 in Q2-2025, driven by one-time gains from debt repayment and asset sales.
Progressing from demonstration to deployment phase, with initial sales to major clients like Ericsson and ongoing client delivery updates.
Financial highlights
Six-month revenue was $578,000, down from $1,543,000 year-over-year.
Gross margin for Q2-2026 was -1.7% due to a one-time overhead accounting adjustment; six-month gross margin was 19.0%, down from 45.9% year-over-year.
Operating expenses for the six months were $3,423,000, up from $3,267,000 year-over-year.
One-time gains from debt repayment and sale of the Tokens.com domain positively impacted results.
Outlook and guidance
Current market for humanoid robots is small, with only about 13,000 units sold last year, but management expects substantial long-term growth and gradual revenue increase over a three- to four-year plan.
Management expects continued product deliveries in coming months, with revenue recognition lagging due to policy.
Confident in the success of the Nasdaq reverse merger, with a 95% probability, pending regulatory review and expected to close before October 31, 2026.
New product launches, including the Ask Aria app and educational robotics kits, are planned for the near future.
Latest events from Realbotix
- Reverse takeover to NASDAQ, $125M valuation, and lifelike AI robots drive growth and visibility.XBOT.F
Investor presentation11 Mar 2026 - Debt-free, scaling robotics and AI, with strong cash and a major Nasdaq deal pending.XBOT.F
Q1 202610 Mar 2026 - Revenue up 121%, gross margin up, net loss narrowed, and company is now debt-free.XBOT.F
Q4 20259 Mar 2026 - Reverse takeover secures Nasdaq listing, majority ownership, and growth capital with no dilution.XBOT.F
M&A announcement13 Feb 2026 - Net income hit $3.4M as assets and revenue soared, with AI robot growth accelerating.XBOT.F
Q3 202423 Jan 2026 - AI-enabled humanoid robots for companionship drive growth in entertainment and healthcare.XBOT.F
2024 Sidoti Virtual Micro-Cap Conference14 Jan 2026 - AI-powered humanoid robots target social needs, with 2025 focused on scaling corporate sales.XBOT.F
Emerging Growth Conference 7711 Jan 2026 - CES debut of lifelike AI robots drives industry demand and plans for major production scale-up.XBOT.F
Emerging Growth Virtual Conference 7810 Jan 2026 - FY-2024 revenue up 378% to $1.3M, with major CES-driven media and product momentum.XBOT.F
Q4 20249 Jan 2026